ANTX

AN2 Therapeutics Inc. Common Stock (ANTX)

Stock · NASDAQ · Health Care

$5.58as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$1.06
Industry
Biotechnology: Pharmaceutical Preparations

AN2 Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • ANTX
    AN2 Therapeutics Inc. Common Stock
    $5.58
    ▼ 2.79%
    Market cap $200.97MP/E
  • KROS
    Keros Therapeutics Inc. Common Stock
    $11.05
    ▼ 1.60%
    Market cap $200.10MP/E
    $9.69$22.55
  • GLSI
    Greenwich LifeSciences Inc. Common Stock
    $15.67
    ▼ 16.34%
    Market cap $198.74MP/E
    $7.78$34.1
  • MSLE
    Satellos Bioscience Inc. Common Stock
    $8.92
    ▼ 7.23%
    Market cap $203.94MP/E
    $7.08$18.98
  • IMUX
    Immunic Inc. Common Stock
    $15.4
    ▼ 5.52%
    Market cap $192.06MP/E
    $5.06$17.43
  • WHWK
    Whitehawk Therapeutics Inc. Common Stock
    $4.65
    ▼ 4.52%
    Market cap $212.98MP/E
    $1.76$5.5
  • NBP
    NovaBridge Biosciences American Depositary Shares
    $1.85
    ▼ 2.38%
    Market cap $185.76MP/E
    $1.46$6.79

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
21.75M
Total value held
$74.17M
Institutional holders
50
Top holders this quarter
  • Unknown3.15M
  • Unknown2.33M
  • Unknown2.22M
  • Unknown1.66M
  • Unknown1.48M
  • Unknown1.01M
  • Unknown1.00M
  • Unknown993.7K
  • Unknown749.0K
  • Unknown713.8K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.